Drug development has focused on reformulating existing drugs and creating alternative methods of drug delivery to improve safety and efficacy. Currently, there are 75 agents in clinical development. Of the 26 agents indicated for neuropathic pain, six specifically target postherpetic neuralgia. Other indications include diabetic peripheral neuropathy, central neuropathic pain due to spinal cord injury or multiple sclerosis and lumbosacral radiculopathy. Nociceptive pain indications include osteoarthritis pain and chronic low back pain.
Related Articles on Pain Management:
Targeted Radiation Alternative Treatment to Surgery for Trigeminal Neuralgia
Pharmacists Stop Stocking Opioids Due to Robberies
12 Statistics on Pain Management Case Revenue by Region
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
